Referenceprogram for angstlidelser hos voksne - Sundhedsstyrelsen

(235) van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive
and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive
compulsive disorder. J.Nerv.Ment.Dis. 1998;186(8):492-499.
(236) Cottraux J, Mollard E, Bouvard M, Marks I. Exposure therapy, fluvoxamine, or combination
treatment in obsessive-compulsive disorder: one-year followup. Psychiatry Res. 1993;49(1):63-75.
(237) Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, et al. Post-treatment
effects of exposure therapy and clomipramine in obsessive-compulsive disorder. Depress.Anxiety
2004;19(4):225-233.
(238) Mawson D, Marks IM, Ramm L. Clomipramine and exposure for chronic obsessive-compulsive
rituals: III. Two year follow-up and further findings. Br.J.Psychiatry 1982;140:11-18.
(239) Kasvikis Y, Marks IM. Clomipramine, self-exposure, and therapist-accompanied exposure in
obsessive-compulsive ritualizers:Two year follow-up. J.Anxiety Disord. 1988(2):291-298.
(240) Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response
of patients with obsessive-compulsive disorder responding to drug treatment. J.Clin.Psychiatry 2005 ;
66(9):1169-1175.
(241) Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P. Cognitive-behavioral therapy
for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial.
J.Clin.Psychiatry 2004;65(7):922-931.
(242) Frommberger U, Stieglitz RD, Nyberg E, Richter H, Novelli-Fischer U, Angenendt J, et al.
Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder
(PTSD): A pilot study. Int.J.Psychiatry Clin.Pract. 2004;8(1):19-23.
(243) Hinton DE, Chhean D, Pich V, Safren SA, Hofmann SG, Pollack MH. A randomized
controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD
and panic attacks: a cross-over design. J.Trauma.Stress 2005;18(6):617-629.
(244) Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive-behavioral therapies
and medications work in combination? Biol.Psychiatry 2002;52(10):987-997.
(245) Hofmann SG, Barlow DH, Papp LA, Detweiler MF. Pretreatment attrition in a comparative
treatment outcome study of panic disorder. Am.J.Psychiatry 1998;155:43-80.
(246) Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy
for anxiety disorders. Cochrane Database Syst.Rev. 2006 Jan 25;(1)(1):CD004998.
(247) Moyer CA, Rounds J, Hannum JW. A Meta-Analysis of Massage Therapy Research. Psychol.
Bull. 2004;130(1):3-18.
(248) Meuret AE, Ritz T, Wilhelm FH, Roth WT. Voluntary hyperventilation in the treatment
of panic disorder--functions of hyperventilation, their implications for breathing training, and
recommendations for standardization. Clin.Psychol.Rev. 2005;25(3):285-306.
1 Referenceprogram for angstlidelser hos voksne